Skip to main content
. 2021 May 19;12:676181. doi: 10.3389/fimmu.2021.676181

Figure 3.

Figure 3

CA-170, an orally administered agent, can directly block the interaction of PD-1/PD-L1 and VISTA/VISTA-receptor and reactivate T cells (85). VISTA, V-domain Ig suppressor of T cell activation, PD-1, Programmed cell death protein-1; PD-L1, Programmed death-ligand 1.